文献速递免疫规划

表达H9N2亚型禽流感病毒血凝素的火鸡疱疹病毒载体疫苗免疫肉鸡的现场生产效率研究

Field production efficiency investigation of broilers immunized with a turkey herpesvirus vector vaccine expressing hemagglutinin from H9N2 subtype avian influenza virus.
PubMed 文献 · Vaccine · 2024-10-14

本研究通过现场试验评估表达H9N2禽流感病毒血凝素的火鸡疱疹病毒载体疫苗(HVT-H9)在有无H9N2自然感染情况下对肉鸡的保护效率和生产性能。结果显示,HVT-H9能诱导携带母源抗体的肉鸡产生HI抗体;在自然感染存在时阻断感染并降低死亡率;无自然感染时略微增加体重并降低料肉比,有自然感染时显著降低死亡率并提高生产效率。

要点

  • HVT-H9能诱导携带母源抗体的肉鸡产生针对H9N2的HI抗体。
  • 存在H9N2自然感染时,HVT-H9免疫阻断感染并降低死亡率。
  • HVT-H9免疫可提高现场生产效率,尤其在自然感染存在时。

核心结论

  • HVT-H9免疫可能阻断H9N2禽流感病毒感染并提高现场生产效率,尤其在存在H9N2自然感染时。

研究设计与样本

  • 在有无H9N2禽流感病毒自然感染的情况下,开展HVT-H9现场试验,评估肉鸡的保护效率和生产性能。

主要发现

  • HVT-H9成功诱导携带母源抗体的肉鸡产生针对H9N2禽流感病毒的HI抗体。
  • 存在H9N2自然感染时,HVT-H9免疫阻断H9N2禽流感病毒感染并降低死亡率。
  • 无H9N2自然感染时,HVT-H9免疫略微增加肉鸡体重并降低料肉比。
  • 存在H9N2自然感染时,HVT-H9免疫显著降低死亡率并提高生产效率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Turkey herpesvirus (HVT) vector vaccine expressing hemagglutinin from the H9N2 AIV, namely HVT-H9, were demonstrated to block H9N2 AIV infection and transmission in chickens. In this study, we evaluated the protection efficiency and production performance of broilers in HVT-H9 field trials in the presence or absence of the H9N2 AIV natural infection. HI titers against H9N2 AIV in broilers harboring maternal antibodies were successfully induced by HVT-H9. In the presence of H9N2 AIV natural infection, immunization with HVT-H9 blocked H9N2 AIV infection and reduced the mortality rate. Importantly, HVT-H9 vaccination slightly increased broiler weight and decreased the feed conversion rate in the absence of the H9N2 AIV natural infection but significantly reduced mortality rates and increased production efficiency during the H9N2 AIV natural infection. In summary, HVT-H9 immunization might block H9N2 AIV infection and improve production efficiency in the field, especially in the presence of H9N2 AIV natural infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Litao L, Feng C, Hongyu Z, et al. Field production efficiency investigation of broilers immunized with a turkey herpesvirus vector vaccine expressing hemagglutinin from H9N2 subtype avian influenza virus. Vaccine. 2024. PMID: 39405642. doi:10.1016/j.vaccine.2024.126436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。